Price target
59.250.000.00%
The 8 analysts offering 1 year price forecasts for TARS have a max estimate of — and a min estimate of —.
Analyst rating
Based on 9 analysts giving stock ratings to TARS in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
TARS EPS for the last quarter is −0.88 USD despite the estimation of −0.92 USD. In the next quarter EPS is expected to reach −0.94 USD. Track more of Tarsus Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Tarsus Pharmaceuticals, Inc. revenue is expected to reach 43.18 M USD. Check out Tarsus Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, TARS price target is 59.25 USD with a max estimate of 75.00 USD and a min estimate of 36.00 USD. Check if this forecast comes true in a year, meanwhile watch Tarsus Pharmaceuticals, Inc. stock price chart and keep track of the current situation with TARS news and stock market news.
We've gathered opinions of 9 analysts rating TARS stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.